HIBISCUS study: Exploring the use of a new drug in patients with sickle cell disease

For this year’s Black History Month, we wanted to highlight one of our research studies, HIBISCUS, which is exploring the use of a new drug, Etavopiat, in patients with sickle cell disease.

By NIHR Wellcome King's Clinical Research Facility at 31 Oct 2024

“Don’t feel like you have to push through”

Research study participant shares their mental health journey, taking part in the SIGNATURE study and mental health in the workplace

By NIHR Wellcome King's Clinical Research Facility at 10 Oct 2024